Some visit links earn us a commission.
Quick verdict
Medvi is the better pick for most patients on overall scoring. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
That said, Zealthy wins on specific dimensions. A bundled cash-pay option that folds the membership and compounded semaglutide into one $297/mo price, plus an insurance-coordination route for branded GLP-1s. The all-in bundle is mid-pack; the medication-only teaser ($151/mo on a quarterly supply) excludes the membership and is not the ongoing all-in.
Side-by-side
| Medvi | Zealthy | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $297/mo (incl. medication) |
| Monthly cost gap | Medvi is $118/mo cheaper than Zealthy | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 2 days | 2 days |
| Consultation type | Asynchronous | Online |
| Affiliate network | Direct | - |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Medvi | Zealthy | |
|---|---|---|
| Pricing transparency | 8/10 | 4/10 |
| Cancellation terms | 8/10 | 4/10 |
| Onboarding experience | 7/10 | 7/10 |
| Medication options | 7/10 | 7/10 |
| Member reviews | 9/10 | 6.4/10 |
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on pricing transparency, cancellation terms, member reviews and runs $118/mo cheaper than Zealthy at the entry tier ($179 vs $297). Over a year that's $1,416 you keep. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
When to choose Zealthy
Best for bundled cash-pay plus insurance help
Cash-pay patients who want the membership and compounded medication billed as one number, or who want help coordinating insurance for a branded GLP-1.
Zealthy wins on tied dimensions on the dimensional scoring. The caveat: Patients who want the lowest possible compounded price, or who do not want a recurring membership. Note also: Regulatory caution: the FDA issued a warning letter to FitRX, LLC (which operates Zealthy) on September 9, 2025 over false or misleading compounded-semaglutide marketing claims.
If cost is your main filter
Medvi is the cheaper monthly: $179 all-in vs $297 for Zealthy. That's $118 a month or $1,416a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $354 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Medvi (month-to-month) and Zealthy (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Medvi cheaper than Zealthy?
Can I switch from Medvi to Zealthy mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
